Did you miss our ESMO presentation? Listen to this interview with Dr. David Braun on Uro Today, where he explains how our glycoproteomic platform, GlycoVision, can lead to the discovery of predictive and prognostic biomarkers for checkpoint inhibitors.
urotoday.com/video-lectures…
urotoday.com/video-lectures…